Reduced expression of Rap1GAP as a prognostic biomarker for primary gastric cancer patients

被引:7
作者
Zhao, Jingjing [1 ,2 ]
Mai, Cong [3 ]
Weng, Desheng [1 ,2 ]
Chen, Changlong [1 ,2 ]
Zhou, Ziqi [1 ,2 ]
Liu, Yuan [1 ,2 ]
Zhou, Zhiwei [1 ,4 ]
Wang, Peng [5 ,6 ]
机构
[1] Sun Yat Sen Univ, State Key Lab Oncol Southern China, Collaborat Innovat Ctr Canc Med, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Biotherapy, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[3] Guangzhou Med Univ, Affiliated Canc Hosp, Dept Abdominal Oncosurg, Guangzhou, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Canc Ctr, Guangzhou, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Dept Emergency Med, Sun Yat Sen Mem Hosp, Guangzhou 510120, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Rap1GAP; gastric cancer; prognosis; survival; PROMOTES INVASION; DOWN-REGULATION; CELL; SURVIVAL; 1P36; PROLIFERATION; PROTEIN; REGION;
D O I
10.3233/CBM-170832
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Rap1GAP, a member of the family of GTPase-activating proteins, is reported to be involved in cancer development and progression. OBJECTIVE: The study aimed to investigate the expression and prognostic value of Rap1GAP in gastric cancer patients. METHODS: Real-time quantitative polymerase chain reaction and western blotting were performed to examine Rap1GAP expression in tumorous and matched adjacent non-tumorous gastric tissues. Immunohistochemical staining was used to analyze Rap1GAP expression in 456 gastric cancer tissues. The correlation between Rap1GAP expression level and clinicopathological features as well as gastric cancer prognosis was analyzed. RESULTS: Rap1GAP expression was remarkably decreased in tumor tissues at mRNA (p = 0.012) and protein (p = 0.034) level. Clinicopathological analysis revealed that low Rap1GAP expression was significantly correlated with tumor size (p = 0.033), histological grade (p = 0.034), T classification (p = 0.012), N classification (p = 0.006) and clinical stage (p = 0.005). Kaplan-Meier survival analysis revealed the association between low Rap1GAP expression and poor survival in gastric cancer patients. Furthermore, multivariate Cox regression analysis showed that Rap1GAP expression was an independent prognostic factor (p = 0.02). CONCLUSION: Rap1GAP may play a significant role in gastric cancer progression and act as a valuable prognostic marker for gastric cancer.
引用
收藏
页码:375 / 384
页数:10
相关论文
共 32 条
[11]   Human SPA-1 gene product selectively expressed in lymphoid tissues is a specific GTPase-activating protein for Rap1 and Rap2 - Segregate expression profiles from a rap1GAP gene product [J].
Kurachi, H ;
Wada, Y ;
Tsukamoto, N ;
Maeda, M ;
Kubota, H ;
Hattori, M ;
Iwai, K ;
Minato, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (44) :28081-28088
[12]   Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas [J].
Lefeuvre, Mathieu ;
Gunduz, Mehmet ;
Nagatsuka, Hitoshi ;
Gunduz, Esra ;
Ali, Mahmoud Al Sheikh ;
Beder, Levent ;
Fukushima, Kunihiro ;
Yamanaka, Noboru ;
Shimizu, Kenji ;
Nagai, Noriyuki .
JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2009, 38 (01) :94-98
[13]   Biomarkers in cancer staging, prognosis and treatment selection [J].
Ludwig, JA ;
Weinstein, JN .
NATURE REVIEWS CANCER, 2005, 5 (11) :845-856
[14]  
McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200
[15]   Rap1GAP promotes invasion via induction of matrix metalloproteinase 9 secretion, which is associated with poor survival in low N-stage squamous cell carcinoma [J].
Mitra, Raj S. ;
Goto, Mitsuo ;
Lee, Julia S. ;
Maldonado, Diana ;
Taylor, Jeremy M. G. ;
Pan, Quintin ;
Carey, Thomas E. ;
Bradford, Carol R. ;
Prince, Mark E. ;
Cordell, Kitrina G. ;
Kirkwood, Keith L. ;
D'Silva, Nisha J. .
CANCER RESEARCH, 2008, 68 (10) :3959-3969
[16]   Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia [J].
Mori, N ;
Morosetti, R ;
Spira, S ;
Lee, S ;
Ben-Yehuda, D ;
Schiller, G ;
Landolfi, R ;
Mizoguchi, H ;
Koeffler, HP .
BLOOD, 1998, 92 (09) :3405-3409
[17]   Loss of Rap1GAP in Papillary Thyroid Cancer [J].
Nellore, Anoma ;
Paziana, Karolina ;
Ma, Changqing ;
Tsygankova, Oxana M. ;
Wang, Yan ;
Puttaswamy, Kanchan ;
Iqbal, Ammarah U. ;
Franks, Susanna R. ;
Lv, Yu ;
Troxel, Andrea B. ;
Feldman, Michael D. ;
Meinkoth, Judy L. ;
Brose, Marcia S. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (03) :1026-1032
[18]   Chemotherapy for metastatic gastric cancer: past, present, and future [J].
Ohtsu, Atsushi .
JOURNAL OF GASTROENTEROLOGY, 2008, 43 (04) :256-264
[19]   Rap1GAP alters leukemia cell differentiation, apoptosis and invasion in vitro [J].
Qiu, Tingting ;
Qi, Xiaofei ;
Cen, Jiannong ;
Chen, Zixing .
ONCOLOGY REPORTS, 2012, 28 (02) :622-628
[20]   ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions [J].
Roux, PP ;
Blenis, J .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2004, 68 (02) :320-+